NG-monomethyl-L-arginine improves survival in a pig model of abdominal sepsis
- 1 September 1998
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 26 (9) , 1490-1499
- https://doi.org/10.1097/00003246-199809000-00015
Abstract
To test the effect of a continuous infusion of the nitric oxide synthase inhibitor N(G)-monomethyl-L-arginine (L-NMMA) on survival rate and hemodynamics in a pig model of endogenous peritoneal live bacterial sepsis. Prospective, randomized trial. Laboratory at a university medical center. Thirty-five pigs with an average weight of 26 kg (range 21 to 33). After surgical preparation, animals (control, n=6) given anesthesia and fluids were observed for 9 hrs. Fifteen experimental animals received 0.5 g of cecal content/kg of body weight intraperitoneally after surgery. Nine of these animals received standard anesthesia and fluids and were observed for 9 hrs or until death. Six animals received a continuous infusion of L-NMMA (10 mg/kg/hr) 3 hrs after sepsis induction. Starting 3 hrs after surgery, five nonrandomized animals were given anesthesia and fluids and received a 6-hr continuous infusion of L-NMMA (10 mg/kg/hr). An additional nine animals were anesthetized and blood samples were taken to determine plasma nitrate concentrations in nonoperated pigs. L-NMMA treatment increased 9-hr survival in septic animals from 11% to 83% (p < .001), prevented a further decrease in mean arterial pressure and restored mean arterial pressure to control levels (p < .00002 vs. nontreated septic animals). Mean pulmonary arterial pressure increased slightly during L-NMMA infusion (p < .0003). Coronary blood flow was preserved during L-NMMA treatment. Cardiac index and urine production reached and maintained control levels during L-NMMA treatment of septic animals. Mean central venous pH did not deteriorate during L-NMMA treatment. Animals treated with L-NMMA had plasma nitrate concentrations similar to nonseptic control animals. The results from the nonseptic control group receiving L-NMMA suggest that a substantial part of the effect of L-NMMA in this model of septic shock may be due to inhibition of the constitutive nitric oxide production. In this porcine model of peritoneal sepsis, infusion of L-NMMA increased survival rate and maintained mean arterial pressure without worsening tissue oxygenation. Coronary blood flow, cardiac index, systemic vascular resistance, and urine production were well maintained during L-NMMA treatment.Keywords
This publication has 46 references indexed in Scilit:
- Serum nitrate levels in patients with severe sepsis and renal failureClinical Intensive Care, 1997
- A New Perspective on the Inhibitory Role of Nitric Oxide in Sympathetic NeurotransmissionBiochemical and Biophysical Research Communications, 1995
- Role of Nitric Oxide on Papillary Blood Flow and Pressure NatriuresisHypertension, 1995
- Chronic Administration of the Nitric Oxide Synthase Inhibitor, L-NAME, Increases Circulating Endothelin Levels in Guinea PigsEndothelium, 1995
- Therapeutic Effects of Imidazolineoxyl N-Oxide Against Endotoxin Shock through Its Direct Nitric Oxide-Scavenging ActivityBiochemical and Biophysical Research Communications, 1994
- Very large-scale, randomized, clinical trials in sepsis and septic shockCritical Care Medicine, 1994
- Negative Inotropic Effects of Cytokines on the Heart Mediated by Nitric OxideScience, 1992
- Nitric oxide from endothelium and smooth muscle modulates responses to sympathetic nerve stimulation: Implications for endotoxin shockBiochemical and Biophysical Research Communications, 1992
- Nitrogen Oxide Levels in Patients After Trauma and During SepsisAnnals of Surgery, 1991
- Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesisBiochemical and Biophysical Research Communications, 1990